Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Calcipotriol; Betamethasone
LEO Pharma A/S
D05AX; D05AX52
Calcipotriol; Betamethasone
50 mcg/g + 0.5 milligram(s)/gram
Gel
Product subject to prescription which may not be renewed (A)
Other antipsoriatics for topical use; calcipotriol, combinations
Marketed
2008-09-12
600 mm 160 mm IIE015-02 - 160 x 600 mm - Page 1 of 2 105 mm 105 mm 300 mm OMA 08/06/2018 Insert, 2 columns Page 1 160 x 600 mm IIE015-02 08/09/2010 JUG 100% Daivobet ® , Dovobet ® , Xamiol ® gel. Space for text: 2 X 67,5 x 580 mm. Material number must be printed on both sides Material number on page 1, OCRB 8pt kerning+10(Quark)/ OCRB MEDIUM 8pt kerning+50(Indesign) Used for: Comments: If you have scalp psoriasis • Before applying Dovobet to the scalp, comb the hair to remove any loose scales. Tilt your head to make sure Dovobet does not run onto your face. It may help to part your hair before you use Dovobet. Apply Dovobet to the affected area with your fingertips, and rub it in gently. WASHING YOUR HAIR BEFORE APPLICATION OF DOVOBET IS NOT NECESSARY. DOVOBET ® GEL DOVOBET ® GEL 1 4 2 5 3 6 SHAKE bottle before use. DOVOBET ® GEL DOVOBET ® GEL 1 4 2 5 3 6 Apply a drop of Dovobet to fingertip. Apply directly to scalp areas where you can feel the raised plaque and rub the Dovobet gel on to the skin. _Depending on the _ _affected area 1-4 g _ _(up to 1 teaspoon) is _ _normally enough._ DOVOBET ® GEL DOVOBET ® GEL 1 4 2 5 3 6 IN ORDER TO ACHIEVE OPTIMAL EFFECT, IT IS RECOMMENDED THAT THE HAIR IS NOT WASHED IMMEDIATELY AFTER APPLICATION OF DOVOBET. LET DOVOBET REMAIN ON THE SCALP DURING THE NIGHT OR DURING THE DAY. WHEN WASHING HAIR AFTER APPLICATION THE FOLLOWING INSTRUCTIONS MIGHT BE USEFUL: IF NECESSARY, REPEAT STEPS 4-6 ONCE OR TWICE. Leave the shampoo on the scalp for a couple of minutes before washing. Wash your hair as usual. DOVOBET ® GEL DOVOBET ® GEL 1 4 2 5 3 6 DOVOBET ® GEL DOVOBET ® GEL 1 4 2 5 3 6 Apply a mild shampoo to the DRY HAIR, especially to those areas where the gel was applied. Duration of treatment • Use the gel once a day. It may be more convenient to use the gel in the evening • The normal initial treatment period is 4 weeks for scalp areas and 8 weeks for non-scalp areas • Your doctor may decide on a different treatment period • Your doctor may decide on repeated treat Read the complete document
Health Products Regulatory Authority 13 November 2019 CRN0098Z2 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dovobet 50 microgram/g + 0.5 mg/g gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One gram of gel contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate). Excipient with known effect Butylhydroxytoluene (E321) 160 micrograms/g gel For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gel. An almost clear, colourless to slightly off-white gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Topical treatment of scalp psoriasis in adults. Topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Dovobet gel should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for "non-scalp" areas. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision. When using calcipotriol containing medicinal products, the maximum daily dose should not exceed 15 g. The body surface area treated with calcipotriol containing medicinal products should not exceed 30% (see section 4.4). _If used on the scalp_ All the affected scalp areas may be treated with Dovobet gel. Usually an amount between 1 g and 4 g per day is sufficient for treatment of the scalp (4 g corresponds to one teaspoon). Special Populations _Renal and hepatic impairment_ The safety and efficacy of Dovobet gel in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated. _Paediatric population_ The safety and efficacy of Dovobet gel in children below 18 years have not been established. Currently available data in children aged 12 to 17 years are described in section 4.8 and 5.1, but no recommendation on a posology can be made. Method of administration Dovobet gel should not be applied direc Read the complete document